Abstract:Microphthalmia-associated transcription factor (MITF) controls melanocyte survival and differentiation through directly regulating the expression of the tyrosinase(TYR)and tyrosinase-related proteins 1 and 2(TYRP1 and TYRP2)genes.MITFmutations have been reported to result in an abnormal melanocyte development and lead to Waardenburg syndrome type 2 (WS2), characterized by variable degrees of sensorineural hearing loss and patchy regional distribution of hypopigmentation. Recently,MITFwas also indicated as a causative gene for a more severe syndrome, the Tietz Syndrome (TS), characterized by generalized hypopigmentation and complete hearing loss. However, few functional studies have been performed to compare the diseases-causing mutations. Here, we analyzed thein vitroactivity of two recent identified WS2-associated mutation (p.R217I and p.T192fsX18) and one TS-associated mutation p.N210K. The R217I MITF retained partial activity, normal DNA-binding ability and nuclear distribution, whereas the T192fsX18MITFfailed to activateTYRpromoter due to loss of DNA-binding activity, and aberrant subcellular localization. The aberrant subcellular localization of T192fsX18 MITF may be caused by deletion of a putative nuclear localization signal (NLS) at aa 213-218 (ERRRRF). Indeed, MITF with deletion of the NLS fragment failed to translocate into the nucleus and activated theTYRpromoter. Tagging this NLS to GFP promoted the green fluorescence protein (GFP) translocated into the nucleus. The surprising finding of our study is that a TS-associatedMITFmutation, N210K, showed comparablein vitroactivity as WT. Thus, the possible involvement ofMITFin TS and its underlying mechanisms still need further investigation.

Experimental Studies on Regulation of PAX3 on Transcriptional Activities of Target Gene MITF

Functional Analysis of Waardenburg Syndrome-Associated PAX3 and SOX10 Mutations: Report of a Dominant-Negative SOX10 Mutation in Waardenburg Syndrome Type II

Identification and Functional Analysis of a Novel Mutation in the PAX3 Gene Associated with Waardenburg Syndrome Type I

Studies on Pathogenesis of Waardenburg Syndrome Type II and Tietz Syndrome Resulting from MITF Gene Mutations

Generation and expression of recombinant eukaryotic expression plasmids of MITF gene and its significance

Molecular pathogenesis of Waardenburg syndrome type Ⅱ resulting from SOX10 gene mutation

Wnt Signaling Pathway Involvement in Genotypic and Phenotypic Variations in Waardenburg Syndrome Type 2 with MITF Mutations

Functional Analysis of MITF Gene Mutations Associated with Waardenburg Syndrome Type 2

Double heterozygous mutations of MITF and PAX3 result in Waardenburg syndrome with increased penetrance in pigmentary defects

Study of Gene Mutation and Pathogenetic Mechanism for a Family with Waardenburg Syndrome

Modeling of Pigmentation Disorders Associated with MITF Mutation in Waardenburg Syndrome Revealed an Impaired Melanogenesis Pathway in Ips-Derived Melanocytes

A novel mutation of the MITF gene in a family with Waardenburg syndrome type 2: A case report.

PAX3 Mutations and Clinical Characteristics in Chinese Patients with Waardenburg Syndrome Type 1.

Two novel mutations of PAX3 and SOX10 were characterized as genetic causes of Waardenburg Syndrome.

Identification and functional analysis of two novel PAX9 mutations.

Identification and Functional Analysis of A Novel Mutation in the Sox10 Gene Associated with Waardenburg Syndrome Type Iv

A Homozygous MITF Mutation Leads to Familial Waardenburg Syndrome Type 4

Microphthalmia-Associated Transcription Factor (MITF): Multiplicity in Structure, Function, and Regulation

Network effect of Wt-mutant p53 interactions and implications on p53 gene therapy.

MITF: A Stream Flowing for Pigment Cells

A Novel Mutation of PAX3 in a Chinese Family with Waardenburg Syndrome.